The Quantum Group Announces Transition to Continental Stock Transfer
01 Aprile 2009 - 1:00PM
PR Newswire (US)
WELLINGTON, Fla. April 1 /PRNewswire-FirstCall/ -- The Quantum
Group, Inc. (NYSE Amex: QGP) (http://www.quantummd.com/) announced
that it has transitioned to Continental Stock Transfer and Trust
Company to act as Transfer Agent of record for the Company. Noel J.
Guillama, Quantum President & CEO, commented, "Continental
Stock Transfer has been in business for more than 40 years and has
a well regarded reputation as a comprehensive and customer-centric
company that can facilitate the unique needs of its clients."
Guillama continued, "We pride ourselves on the quality of
communications with our shareholders and have great confidence that
Continental will bring added value to these relationships through
their professionalism and efficiency. We welcome all interested
parties to visit our website http://www.quantummd.com/ and sign up
to receive our e-news that is shared with our shareholders and
friends." The Continental client base ranges from non-trading
companies to those listed on the NASDAQ and AMEX exchanges.
Continental services approximately 500 issuer clients and over
230,000 Shareholders. Susan Gallagher, Executive Vice President and
Chief Administrative Officer leads the team responsible for
management of shareholder relations and stock issuance and noted,
"As Quantum continues to grow, our needs and expectations for
shareholder relations have evolved as well. Implementation of 21st
Century technology to transform the healthcare industry through our
PWeR system is a primary focal point of our continued corporate
development. We recognized very quickly that the technology-driven
efficiencies of Continental would create a cost and time savings
for our Company that would transcend the impact of transitioning
this function. We are excited to be working with this high caliber
company and even more so for the level of quality service we
believe it will bring for our shareholders." Continental Stock
Transfer is located at 17 Battery Place, 8th Fl, New York, NY 10004
and the phone number is (212) 509-4000. About The Quantum Group,
Inc. The Quantum Group is an innovation-driven Healthcare Services
Organization (HSO) that provides business process solutions,
service chain management, strategic consulting and leading-edge
technology to the healthcare industry. Quantum has developed and
deployed PWeR(TM), a cutting-edge healthcare technology platform,
with numerous patent-pending components, that has been designed to
bridge the gaps of communication and exchange of patient
information throughout the healthcare industry. PWeR can integrate
all of the functions a physician/provider, hospital, clinic and
related professionals utilize in one patient-centric, Web based
platform and falls well within the economic incentives offered by
the new $19 billion Stimulus Package for healthcare information
technology. We believe we are positioned to be a catalyst for
change as we take aim at the $700 billion inefficiency gap in the
United States healthcare industry. Certain statements contained in
this news release, which are not based on historical facts, are
forward-looking statements as the term is defined in the Private
Securities Litigation Reform Act of 1995, and are subject to
substantial uncertainties and risks in part detailed in the
respective company's Securities and Exchange Commission 10-KSB,
10-QSB, S-8, SB-2, S-1 and 8-K filings (and amendments thereto)
that may cause actual results to materially differ from
projections. Forward-looking statements can be identified by the
use of words such as "expects," "plans," "will," "may,"
"anticipates," "believes," "should," "intends," "estimates,"
"could," and other words of similar meaning. These statements are
subject to risks and uncertainties that cannot be predicted or
quantified and, consequently, actual results may differ materially
from those expressed or implied by these forward-looking
statements. Such risk factors include, without limitation, the
ability of the Company to properly execute its business model, to
raise substantial and immediate additional capital to implement its
business model, to continue revenue growth trend in fiscal year
2009, to control patient medical cost relative to income received,
to attract and retain executive, management and operational
personnel, to continue growing its patient base, to negotiate
favorable current debt and future capital raises, to negotiate
favorable agreements with a diversified provider base and to
continue to supply the services needed by its HMO clients as well
as physician clients. We have further risk in the deployment of our
technology platform, the utilization by our clients, technical and
software setbacks, cost of development, as well as the capital to
deploy it. We are subject further to interruptions of service.
Company does not undertake any obligation to publicly update any
forward-looking statements. As a result, investors should not place
undue reliance on these forward-looking statements. FOR MORE
INFORMATION, PLEASE CONTACT: RedChip Companies Dave Gentry:
407.644.4256, Ext. 104 or PR Financial Marketing Jim Blackman:
713.256.0369 or The Quantum Group, Inc. Danielle Amodio:
561.798.9800 DATASOURCE: The Quantum Group, Inc. CONTACT: Dave
Gentry of RedChip Companies, +1-407-644-4256, Ext. 104, ; or Jim
Blackman of PR Financial Marketing, +1-713-256-0369, ; or Danielle
Amodio of The Quantum Group, Inc., +1-561-798-9800, Web Site:
http://www.thequantumgroupinc.com/ http://www.quantummd.com/
Copyright